This market resolves to YES if, at any point before January 1, 2041, at least one sovereign nation explicitly legalizes, formally permits, or officially licenses the clinical use of heritable human genome modification (germline editing) specifically for non-medical genetic enhancement (e.g., optimization of cognitive, cosmetic, or physical traits like intelligence, height, or strength).

This market resolves to NO if the clinical practice of genetic embryo modification remains restricted globally to strictly therapeutic purposes (e.g., curing hereditary diseases like Huntington's or Cystic Fibrosis) or remains entirely illegal worldwide.

Resolution will be based on official government publications, statutory text, or major international news and scientific outlets (e.g., Nature, Science, The World Health Organization, Reuters).